netFormulary
 Report : A-Z CDF items in Formulary 11/04/2021 10:54:14
[Back]
 
Section Status CDF Name
08.01.05 Formulary Cancer Drugs Fund Atezolizumab Tecentriq®
08.01.01 Formulary Cancer Drugs Fund Bendamustine 
08.01.05 Formulary Cancer Drugs Fund Bevacizumab Avastin®
08.01.05 Formulary Cancer Drugs Fund Bortezomib Velcade®
08.01.05 Formulary Cancer Drugs Fund Brentuximab vedotin Adcetris®
08.01.05 Formulary Cancer Drugs Fund Cabozantinib Cometriq®
08.01.05 Formulary Cancer Drugs Fund Cetuximab Erbitux®
08.01.05 Formulary Cancer Drugs Fund Crizotinib Xalkori®
08.01.02 Formulary Cancer Drugs Fund Doxorubicin Caelyx®
08.01.05 Formulary Cancer Drugs Fund Eribulin Halaven®
08.01.05 Formulary Cancer Drugs Fund Everolimus Afinitor®
08.01.05 Formulary Cancer Drugs Fund Ibrutinib 
08.02.04 Formulary Cancer Drugs Fund Lenalidomide 
08.02.04 Formulary Cancer Drugs Fund Nivolumab Opdivo®
08.03.04.01 Formulary Cancer Drugs Fund Palbociclib Ibrance®
08.01.03 Formulary Cancer Drugs Fund Pemetrexed Alimta®
08.01.05 Formulary Cancer Drugs Fund Pertuzumab Perjeta®
08.03.04.01 Formulary Cancer Drugs Fund Ribociclib Kisqali®
08.01.05 Formulary Cancer Drugs Fund Sorafenib Nexavar®
08.01.05 Formulary Cancer Drugs Fund Venetoclax Venclyxto®
Isle of Wight